I still remember entering the Hall at Boston ́s Children Hospital, going to register and being asked The meat on a rotating spit with its bright red/orange chili-based marinade (spicy but not hot) catches Mariachi song: I typically do not sing to these since they are dear to Mexican childhood memories, and Don’t be surprised if you find yourself singing Daddy Yankee’s “Gasolina” from the top of your lungs

GPCR Matchmaking Meet Mark Schmeizl, our Chief Matchmaker.

GPCR Matchmaking Mark Schmeizl, our Chief Matchmaker, can help you find your perfect match if you want

Our Chief Matchmaker, Mark Schmeizl, had a great conversation about this position with Beth Fleck, Director integrators for mapping G-protein-coupled receptor agonists Development of a synthetic relaxin-3/INSL5 chimeric

Our Chief Matchmaker, Mark Schmeizl, had a great conversation about this position with Beth Fleck, Director MacDonald as Chief Executive Officer Nxera Pharma Announces Exclusive Supply and Distribution Agreement

As Chief Matchmaker, I recently had the pleasure of speaking with Beth Fleck, Director of In Vitro Pharmacology By: Mark Schmeizl Chief Matchmaker at Dr. GPCR

Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease (IBD) Domain Therapeutics and Chime

Function Time-resolved cryo-EM of G-protein activation by a GPCR Industry News Domain Therapeutics and Chime

thuringiensis Industry News Domain Therapeutics announces the promotion of Stephan Schann to the role of Chief

MacDonald as Chief Business Officer.

Jude Children’s Research Hospital adds $13 million project to Research Collaboratives Program AIRSUPRA

Empowering the ML Community in Molecular Predictive Modelling NanoImaging Services Appoints John Rigg as Chief

Osmotic stress studies of G-protein-coupled receptor rhodopsin activation GPCR Binders, Drugs, and more Chimeric company Sosei Group Announces Appointment of Experienced Pharmaceutical Executive Toshihiro Maeda as Chief

Our Chief Matchmaker, Mark Schmeizl, is here to assist you. biomarkers beyond NET: a paired immunohistochemistry approach The combination of brentuximab vedotin and chidamide

Let Mark Schmeizl, our Chief Matchmaker help. Contact him by filling out this form.

FFAR4 for type 2 diabetes mellitus therapy Industry News OMass Therapeutics Welcomes Melissa Faris as Chief

Dictyostelium Reviews, GPCRs, and more Network pharmacology -based study on the mechanism of traditional Chinese

conditions Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child Addex mGlu2 NAM Cognition Program Receives €4 Million Grant Confo Therapeutics Appoints Stephen Dowd As Chief

oral squamous cell carcinoma (OSCC) by regulating the signaling pathway of miR-19a/GRK6/GPCRs/PKC in a Chinese

transmembrane proteins characterization in drug discovery Confo Therapeutics Appoints Stephen Dowd As Chief

protein-coupled receptors relevant to schizophrenia Re-routing GPR56 signaling using Gα12/13 G protein chimeras

Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating

Novartis bolsters innovative medicines strategy and renal pipeline with agreement to acquire Chinook

Andrew Hopkins, Exscientia's CEO, will speak at the University of Chicago's Distinguished Seminar Series

Dynamics Postdoc in lipid regulation of GPCRs Postdoctoral positions, biophysics of transporters and GPCRs Chief

B. et al. (2021) Chimia, 75(6), 489–494. https://doi.org/10.2533/chimia.2021.489 · Description

Dynamics Postdoc in lipid regulation of GPCRs Postdoctoral positions, biophysics of transporters and GPCRs Chief

The chimeric antigen receptor T cell therapy could also be a way to target tumor cells expressing ectopic